ARNOLD L. SMITH

Professor Arnold L. Smith, M.D. is Full Member & Director of Bacterial Pathogenesis of the Seattle Biomedical Research Institute and one of the world leaders in bacterial pathogenesis. Dr. Smith is serving now and has served as PI/PD on numerous grants from NIAID, NIGMS, NICHD, NHLBI, & Cystic Fibrosis Foundation. Dr. Smith began working on H. influenzae in 1969 when he joined the faculty of Harvard Medical School. Among his numerous outstanding achievements: he was part of the team along with Drs. D.H. Smith, P. Anderson, and R. Insel, which developed Hib-conjugate vaccine, which is now recommended for administration to every infant born in the USA. He also developed the infant rat model of invasive H. influenzae disease, which led to "proof of principle" studies confirming the utility of anti-type b capsular antibodies. He has published over 100 peer-reviewed manuscripts addressing the pathogenesis of disease in cell culture and subhuman primates, and on the mechanisms of antibiotic resistance. Dr. Smith is long stand collaborator and advisor on Haemophilus, one of the model organisms under study at BIATECH.

DAVID J. ARPASI

David J. Arpasi is the President of In-Red Services Corporation, a firm which provides tax consultation and tax preparation services along with other traditional finance and accounting services. Mr. Arpasi was awarded an M.B.A. in Finance and Business Management from Indiana University and also holds a B.S. in Business from Indiana University. He was elected to membership in Beta Gamma Sigma. Prior to developing his own corporation, Mr. Arpasi was a senior financial manager for three major corporations as well as a veteran of the United States Air Force. He has been involved with BIATECH since its inception providing tax, finance, and accounting expertise.

EUGENE KOLKER

Until 2002 Dr. Kolker was Computation Biology Lead at ISB, and recently Eugene became the Affiliate Scientist at the Pacific Northwest National Laboratory, Richmond, WA. In 2002, Dr. Kolker started BIATECH and serves as its President and Director. Dr. Kolker has extensive computational and molecular biology experience on genomics and proteomics, statistical and algorithmic development, data analysis and integration and has been a member of the Board of Directors for the International Society for Computational Biology. In 2001 he was invited to and accepted the position of Editor-in-Chief of a new journal "OMICS A Journal of Integrative Biology". Dr. Kolker serves as a Head of the Executive Council.
     More details

HENRY G. LIEBMAN

President, founder, and co-owner of American Life, Mr. Henry G. Liebman has over twenty years experience in immigration, real estate, and recently biotechnology-related law as Managing Partner of Coe Nordwall Liebman LLC and currently at Liebman-Mimbu PLLC. Mr. Liebman is the author of several books on immigration law and was the founder of Northwest International Bank, serving as the bank's first Chairman of the Board and now as a director and Loan Committee member. His experience in purchasing, managing the development of commercial-industrial properties and biotechnology startups, coupled with his banking and investment experience, has given Mr. Liebman his unique business background. This unusual depth of skill in business, finance, and law, especially in biotechnology-related issues, is invaluable to BIATECH. Mr. Liebman currently serves as BIATECH's Secretary.

MONICA GIANNI

Ms. Monica Gianni, CPA, JD, LLM works at BTI International Law Office LLC and has over twenty years experience as a lawyer and CPA, and currently specializes in tax and legal issues related to nonprofit and exempt organizations and international businesses. She and is also an Adjunct Professor at the University of Washington Law School and the author of numerous articles on taxation published in national tax journals. Since BIATECH's inception, she has played an instrumental role in BIATECH's development and especially in establishing its legal structure and consulting on legal and tax issues.